Proteasome inhibitors suppress formation of polyglutamine-induced nuclear inclusions in cultured postmitotic neurons

Woo Yang Kim, Craig Horbinski, Wade Sigurdson, Dennis Higgins

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

At least nine neurodegenerative disorders are caused by expansion of polyglutamine repeats in various genes. This expansion induces the formation of nuclear inclusions (NI) within various cell types. In this study, we developed a model for polyglutamine diseases using primary cultures of sympathetic neurons from the superior cervical ganglia of prenatal rat pups. Transfection with a plasmid encoding 127 glutamine repeats causes NI to develop in ∼70% of the sympathetic neurons within 6 days. In addition, it causes somatic atrophy and inhibits dendritic growth. The NIs contain ubiquitinated proteins and sequester the molecular chaperone heat shock protein 70 (Hsp70). We found that two specific proteasome inhibitors, lactacystin and CEP1612, suppress thezformation of polyglutamine-induced NI. In addition, lactacystin treatment induced the removal of preexisting NI. Western blotting and immunocytochemistry revealed that lactacystin and CEP1612 strongly induce the expression of Hsp70, whereas less specific proteasome inhibitor such as N-acetyl-Leu-Leu-Norleucinal does not. Coexpression of 127 glutamines with a plasmid encoding wild-type Hsp70 gene resulted in a marked reduction of the percentage of neurons containing NI. In addition, transfection with plasmids encoding mutant Hsp70 blocked the effects of lactacystin. These findings further implicate Hsp70 as a neuroprotective molecule and they suggest the potential utility of certain proteasome inhibitors in the treatment of polyglutamine diseases.

Original languageEnglish (US)
Pages (from-to)1044-1056
Number of pages13
JournalJournal of Neurochemistry
Volume91
Issue number5
DOIs
StatePublished - Dec 1 2004

Fingerprint

Intranuclear Inclusion Bodies
Proteasome Inhibitors
HSP70 Heat-Shock Proteins
Neurons
Plasmids
Glutamine
Transfection
leucylleucine
Genes
Ubiquitinated Proteins
Superior Cervical Ganglion
Molecular Chaperones
Mutant Proteins
Neurodegenerative Diseases
Atrophy
Rats
Western Blotting
Immunohistochemistry
polyglutamine
Molecules

Keywords

  • Heat shock protein 70
  • Molecular chaperone
  • Nuclear inclusion
  • Polyglutamine diseases
  • Proteasome inhibitor

ASJC Scopus subject areas

  • Biochemistry
  • Cellular and Molecular Neuroscience

Cite this

Proteasome inhibitors suppress formation of polyglutamine-induced nuclear inclusions in cultured postmitotic neurons. / Kim, Woo Yang; Horbinski, Craig; Sigurdson, Wade; Higgins, Dennis.

In: Journal of Neurochemistry, Vol. 91, No. 5, 01.12.2004, p. 1044-1056.

Research output: Contribution to journalArticle

Kim, Woo Yang ; Horbinski, Craig ; Sigurdson, Wade ; Higgins, Dennis. / Proteasome inhibitors suppress formation of polyglutamine-induced nuclear inclusions in cultured postmitotic neurons. In: Journal of Neurochemistry. 2004 ; Vol. 91, No. 5. pp. 1044-1056.
@article{e2286b62856649a0a2ba665df92d2e79,
title = "Proteasome inhibitors suppress formation of polyglutamine-induced nuclear inclusions in cultured postmitotic neurons",
abstract = "At least nine neurodegenerative disorders are caused by expansion of polyglutamine repeats in various genes. This expansion induces the formation of nuclear inclusions (NI) within various cell types. In this study, we developed a model for polyglutamine diseases using primary cultures of sympathetic neurons from the superior cervical ganglia of prenatal rat pups. Transfection with a plasmid encoding 127 glutamine repeats causes NI to develop in ∼70{\%} of the sympathetic neurons within 6 days. In addition, it causes somatic atrophy and inhibits dendritic growth. The NIs contain ubiquitinated proteins and sequester the molecular chaperone heat shock protein 70 (Hsp70). We found that two specific proteasome inhibitors, lactacystin and CEP1612, suppress thezformation of polyglutamine-induced NI. In addition, lactacystin treatment induced the removal of preexisting NI. Western blotting and immunocytochemistry revealed that lactacystin and CEP1612 strongly induce the expression of Hsp70, whereas less specific proteasome inhibitor such as N-acetyl-Leu-Leu-Norleucinal does not. Coexpression of 127 glutamines with a plasmid encoding wild-type Hsp70 gene resulted in a marked reduction of the percentage of neurons containing NI. In addition, transfection with plasmids encoding mutant Hsp70 blocked the effects of lactacystin. These findings further implicate Hsp70 as a neuroprotective molecule and they suggest the potential utility of certain proteasome inhibitors in the treatment of polyglutamine diseases.",
keywords = "Heat shock protein 70, Molecular chaperone, Nuclear inclusion, Polyglutamine diseases, Proteasome inhibitor",
author = "Kim, {Woo Yang} and Craig Horbinski and Wade Sigurdson and Dennis Higgins",
year = "2004",
month = "12",
day = "1",
doi = "10.1111/j.1471-4159.2004.02788.x",
language = "English (US)",
volume = "91",
pages = "1044--1056",
journal = "Journal of Neurochemistry",
issn = "0022-3042",
publisher = "Wiley-Blackwell",
number = "5",

}

TY - JOUR

T1 - Proteasome inhibitors suppress formation of polyglutamine-induced nuclear inclusions in cultured postmitotic neurons

AU - Kim, Woo Yang

AU - Horbinski, Craig

AU - Sigurdson, Wade

AU - Higgins, Dennis

PY - 2004/12/1

Y1 - 2004/12/1

N2 - At least nine neurodegenerative disorders are caused by expansion of polyglutamine repeats in various genes. This expansion induces the formation of nuclear inclusions (NI) within various cell types. In this study, we developed a model for polyglutamine diseases using primary cultures of sympathetic neurons from the superior cervical ganglia of prenatal rat pups. Transfection with a plasmid encoding 127 glutamine repeats causes NI to develop in ∼70% of the sympathetic neurons within 6 days. In addition, it causes somatic atrophy and inhibits dendritic growth. The NIs contain ubiquitinated proteins and sequester the molecular chaperone heat shock protein 70 (Hsp70). We found that two specific proteasome inhibitors, lactacystin and CEP1612, suppress thezformation of polyglutamine-induced NI. In addition, lactacystin treatment induced the removal of preexisting NI. Western blotting and immunocytochemistry revealed that lactacystin and CEP1612 strongly induce the expression of Hsp70, whereas less specific proteasome inhibitor such as N-acetyl-Leu-Leu-Norleucinal does not. Coexpression of 127 glutamines with a plasmid encoding wild-type Hsp70 gene resulted in a marked reduction of the percentage of neurons containing NI. In addition, transfection with plasmids encoding mutant Hsp70 blocked the effects of lactacystin. These findings further implicate Hsp70 as a neuroprotective molecule and they suggest the potential utility of certain proteasome inhibitors in the treatment of polyglutamine diseases.

AB - At least nine neurodegenerative disorders are caused by expansion of polyglutamine repeats in various genes. This expansion induces the formation of nuclear inclusions (NI) within various cell types. In this study, we developed a model for polyglutamine diseases using primary cultures of sympathetic neurons from the superior cervical ganglia of prenatal rat pups. Transfection with a plasmid encoding 127 glutamine repeats causes NI to develop in ∼70% of the sympathetic neurons within 6 days. In addition, it causes somatic atrophy and inhibits dendritic growth. The NIs contain ubiquitinated proteins and sequester the molecular chaperone heat shock protein 70 (Hsp70). We found that two specific proteasome inhibitors, lactacystin and CEP1612, suppress thezformation of polyglutamine-induced NI. In addition, lactacystin treatment induced the removal of preexisting NI. Western blotting and immunocytochemistry revealed that lactacystin and CEP1612 strongly induce the expression of Hsp70, whereas less specific proteasome inhibitor such as N-acetyl-Leu-Leu-Norleucinal does not. Coexpression of 127 glutamines with a plasmid encoding wild-type Hsp70 gene resulted in a marked reduction of the percentage of neurons containing NI. In addition, transfection with plasmids encoding mutant Hsp70 blocked the effects of lactacystin. These findings further implicate Hsp70 as a neuroprotective molecule and they suggest the potential utility of certain proteasome inhibitors in the treatment of polyglutamine diseases.

KW - Heat shock protein 70

KW - Molecular chaperone

KW - Nuclear inclusion

KW - Polyglutamine diseases

KW - Proteasome inhibitor

UR - http://www.scopus.com/inward/record.url?scp=9744278199&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=9744278199&partnerID=8YFLogxK

U2 - 10.1111/j.1471-4159.2004.02788.x

DO - 10.1111/j.1471-4159.2004.02788.x

M3 - Article

C2 - 15569248

AN - SCOPUS:9744278199

VL - 91

SP - 1044

EP - 1056

JO - Journal of Neurochemistry

JF - Journal of Neurochemistry

SN - 0022-3042

IS - 5

ER -